Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study
By:
Authors
Marcin Kunecki
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland
Tomasz Oleksy
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland
Jerzy Nozynski
Department of Histology and Embryology, Medical University of Silesia, Katowice, Poland
Piotr Podolec
Department of Cardiac and Vascular Diseases, John Paul II Hospital, Jagiellonian University Medical College, Kraków, Poland
Jolanta Biernat
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland
Marek Andrzej Deja
Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland
Krzysztof Stanislaw Golba
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland
Wojciech Plazak
Department of Cardiac and Vascular Diseases John Paul II Hospital, Jagiellonian University Medical College, Kraków, Poland
Language: English
Page range: 219 - 223
Submitted on: Aug 30, 2022
Accepted on: Dec 11, 2022
Published on: Feb 9, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2023 Marcin Kunecki, Tomasz Oleksy, Jerzy Nozynski, Piotr Podolec, Jolanta Biernat, Marek Andrzej Deja, Krzysztof Stanislaw Golba, Wojciech Plazak, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.